HLB bioStep Co., Ltd. engages in the provision of clinical research services. It operates through the following business divisions: Non-Clinical Contract Research Organizations (CRO), Bioinfrastructure, and Pet Medical. The Non-Clinical CRO business division focuses on pharmacology and toxicity evaluation. The Bioinfrastructure business division is invloved in the design, construction, and maintenance of animal testing facilities, as well as supply of equipment and materials. The Pet Medical business division distributes and sells veterinary medicines. The company was founded on April 19, 2012 and is headquartered in Inchon, South Korea.